Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Llewellyn, David ^a   Miura, Kazutoyo ^b   Fay, Michael P ^b   Williams, Andrew R ^a,f   Murungi, Linda M ^a,c   Shi, Jianguo ^d   Hodgson, Susanne H ^a   Douglas, Alexander D ^a   Osier, Faith H ^c   Fairhurst, Rick M ^b   Diakite, Mahamadou ^e   Pleass, Richard J ^d   Long, Carole A ^b   Draper, Simon J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF BAMAKO   (Mali)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MALARIA VACCINE; PROTOZOON ANTIBODY;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MALARIA FALCIPARUM; METABOLISM; NEUTROPHIL; PARASITOLOGY; PLASMODIUM FALCIPARUM; REPRODUCIBILITY; RESPIRATORY BURST;

ADULT; ANTIBODIES, PROTOZOAN; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; HUMANS; IN VITRO TECHNIQUES; MALARIA VACCINES; MALARIA, FALCIPARUM; NEUTROPHILS; PLASMODIUM FALCIPARUM; RECEPTORS, FC; REPRODUCIBILITY OF RESULTS; RESPIRATORY BURST;

EID: 84941770213     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14081     Document Type: Article

References (57)

1. The malERA Consultative Group on Vaccines. A Research Agenda for Malaria Eradication: Vaccines. PLoS Med 8, e1000398 (2011).
2. Murray, C. J. L. et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379, 413-431 (2012).
3. World Health Organisation. World Malaria Report 2013. (Geneva, 2013).
4. Langhorne, J., Ndungu, F. M., Sponaas, A.-M. & Marsh, K. Immunity to malaria: more questions than answers. Nat Imm 9, 725-732 (2008).
5. Wright, G. J. & Rayner, J. C. Plasmodium falciparum erythrocyte invasion: combining function with immune evasion. PLoS Path 10, e1003943 (2014).
6. Goodman, A. L. & Draper, S. J. Blood-stage malaria vaccines - recent progress and future challenges. Ann Trop Med Parasitol 104, 189-211 (2010).
7. Halbroth, B. R. & Draper, S. J. Recent developments in malaria vaccinology. Adv Parasitol 88, 1-49 (2015).
8. Duncan, C. J. A. et al. Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. PLoS ONE 6, e22271 (2011).
9. Duncan, C., Hill, A. V. S. & Ellis, R. Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? Hum Vaccin Immunother 8, 706-714 (2012).
10. Hill, D. L. et al. Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites. PLoS ONE 7, e51692 (2012).
11. Osier, F. H. et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Medicine 12, 108 (2014).
12. Turrini, F. et al. Phagocytosis of Plasmodium falciparum-infected human red blood cells by human monocytes: involvement of immune and nonimmune determinants and dependence on parasite developmental stage. Blood 80, 801-808 (1992).
13. Celada, A., Cruchaud, A. & Perrin, L. H. Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes. J Parasitol 69, 49-53 (1983).
14. Chan, C. L., Rénia, L. & Tan, K. S. W. A simplified, sensitive phagocytic assay for malaria cultures facilitated by flow cytometry of differentially-stained cell populations. PLoS ONE 7, e38523 (2012).
15. Boyle, M. J. et al. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria. Immunity 42, 580-590 (2015).
16. Lunel, F. & Druilhe, P. Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect Immun 57, 2043-2049 (1989).
17. Bouharoun-Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T. & Druilhe, P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172, 1633-1641 (1990).
18. Jepsen, M. P. G. et al. The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas. J Infect Dis 208, 479-488 (2013).
19. Joos, C. et al. Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS ONE 5, e9871 (2010).
20. Kapelski, S., Klockenbring, T., Fischer, R., Barth, S. & Fendel, R. Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparum. J Leuk Biol 96, 1-12 (2014).
21. Pleass, R. J. et al. Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection. Blood 102, 4424-4430 (2003).
22. Kumaratilake, L. M. & Ferrante, A. Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry. Clin Diagn Lab Immunol 7, 9-13 (2000).
23. Sun, T. & Chakrabarti, C. Schizonts, merozoites, and phagocytosis in falciparum malaria. Ann Clin Lab Sci 15, 465-469 (1985).
24. Llewellyn, D. et al. Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome. J Leuk Biol 95, 369-382 (2014).
25. Clark, I. A. & Hunt, N. H. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun 39, 1-6 (1983).
26. Murray, H. Susceptibility of leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med 153, 1302-1315 (1981).
27. Murray, H. W. & Cohn, Z. A. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J Exp Med 150, 938-949 (1979).
28. Friedman, M. J. Oxidant damage mediates variant red cell resistance to malaria. Nature 280, 245-247 (1979).
29. Greve, B. et al. High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J Infect Dis 179, 1584-1586 (1999).
30. Sanni, L. A. et al. Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? J Infect Dis 179, 217-222 (1999).
31. Sheehy, S. H. et al. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol Ther 20, 2355-2368 (2012).
32. 19). BMC biotechnol 11, 77-94 (2011).
33. McIntosh, R. S. et al. The importance of human FcgRI in mediating protection to malaria. PLoS Path 3, e72 (2007).
34. Koch, G. G. Intraclass Correlation Coefficient. in Encyclopedia of Statistics, Vol. 4 (eds. Kotz, S. & Johnson, N. L.) (Wiley, New York, 1983).
35. Camous, L. et al. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 117, 1340-1349 (2011).
36. Morgan, B. P. Complement membrane attack on nucleated cells: resistance, recovery and non lethal effects. Biochem J 264, 1-14 (1989).
37. Voice, J. K. & Lachmann, P. J. Neutrophil Fcγ and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes. Eur J Immunol 27, 2514-2523 (1997).
38. Biswas, S. et al. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure. PLoS One 9, e107903 (2014).
39. st May 2015.
40. Miura, K. et al. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 26, 193-200 (2008).
41. Pan, L., Kreisle, R. & Shi, Y. Detection of Fcg receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-a) and interferon-gamma (IFN-g). Clin Exp Immunol 112, 533-538 (1998).
42. Omi, K. et al. Fcγ receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int 51, 361-366 (2002).
43. Cooke, G. S. et al. Association of Fcg receptor Ila (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg 69, 565-568 (2003).
44. Shi, Y. P. et al. Fcγ receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J Infect Dis 184, 107-111 (2001).
45. Ouma, C. et al. Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children. Hum Genet, 131, 289-299 (2012).
46. Polhemus, M. E. et al. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research. Vaccine 25, 4203-4212 (2007).
47. Aoki, S. et al. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J Biol Chem 277, 47533-47540 (2002).
48. Sheehy, S. H. et al. Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. PLoS One 7, e31208 (2012).
49. Marsh, K. & Kinyanjui, S. Immune effector mechanisms in malaria. Parasite Immunol 28, 51-60 (2006).
50. Williams, A. R. et al. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Path 8, e1002991 (2012).
51. Lambros, C. & Vanderberg, J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65, 418-420 (1979).
52. Rosenthal, P. J., Kim, K., McKerrow, J. H. & Leech, J. H. Identification of three stage-specific proteinases of Plasmodium falciparum. J Exp Med 166, 816-821 (1987).
53. Salmon, B. L., Oksman, A. & Goldberg, D. E. Malaria parasite exit from the host erythrocyte: A two-step process requiring extraerythrocytic proteolysis. PNAS 98, 271-276 (2001).
54. Siemsen, D. W., Schepetkin, I. A., Kirpotina, L. N., Lei, B. & Quinn, M. T. Neutrophil isolation from nonhuman species. in Neutrophil Methods and Protocols, Vol. 412 (eds. Quinn, M. T., DeLeo, F. R. & Bokoch, G. M.) 21-34 (Humana Press, Totowa, 2007).
55. Sheehy, S. H. et al. Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors. Mol Ther 19, 2269-2276 (2011).
56. Chevan, A. & Sutherland, M. Hierarchical partitioning. Am Stat 45, 90-96 (1991).
57. Efron, B. & Tibshirani, R. An introduction to the bootstrap, (CRC press, New York, 1993).